Fecal calprotectin in healthy children aged 4–16 years
Abstract Reference values of fecal calprotectin (fCP) have not been convincingly established in children. We aimed to investigate fCP concentrations in a larger population of healthy children aged 4–16 years to analyze more in depth the behavior of fCP in this age range and to determine if cut-off l...
Guardado en:
Autores principales: | María Roca, Ana Rodriguez Varela, Eva Carvajal, Ester Donat, Francisco Cano, Ana Armisen, Maria Jose Vaya, Helena Ekoff, David Hervas, Niclas Rydell, Carmen Ribes-Koninckx |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95840dbf9cc8489eaaac08465ea61961 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016) -
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
por: Hajar Shokri-Afra, et al.
Publicado: (2021) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021) -
Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
por: Magdalena Koszewicz, et al.
Publicado: (2021) -
A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
por: Jong-Mi Lee, et al.
Publicado: (2021)